Flavio Milana

[Iswanto Sucandy MD @IswantoSucandy]

Inaugural Robotic Pancreas and Liver Surgery Course for IRCAD North America will take place on April21-24.
This will be an excellent course for all surgical oncologists, liver Transplant surgeons and Hepatopancreatobiliary surgeons.
Course is directed by Prof John Martinie in NC

[Simone Conci @conci_simone]

Talks 🗣️, friends 🤗 and squirrels 🐿️ at the International Society of Liver Surgeons Congress in Toronto 🍁

[GUIDO TORZILLI @TorzilliGuido]

New operations & concepts of oncological radicality, led parenchymal-sparing surgery (scaffold-sparing surgery) to its highest expression. All of that now on @AnnalsofSurgery

@HUNIMED @HumanitasMilano @IHPBA @AHPBA @EAHPBA @APHPBA @SSATNews @IASGO_1988 @IrcadFrance @SocSurgOnc

[GUIDO TORZILLI @TorzilliGuido]

Pleased to announce the release of another scaffold sparing solution for boosting one stage removal of multiple bilobar colorectal liver metastases: SLICED LIVER HEPATECTOMY
@HumanitasMilano @HUNIMED
@IHPBA @AHPBA @EAHPBA @APHPBA @IASGO_1988 @SSATNews @SocSurgOnc @Aicep4

[Society of Surgical Oncology @SocSurgOnc]

From the June Issue of @AnnSurgOncol: Long-Term Outcomes According to #SurgicalMargin in Mass-Forming #Cholangiocarcinoma : The Role of R1vasc @Fla_doc @TorzilliGuido @simonefamularo

https://t.co/J9SPNR3ArE

@vitor__moutinho
@SyedAAhmad5

[Annals of Surgical Oncology @AnnSurgOncol]

June Issue: Long-Term Outcomes According to #SurgicalMargin in Mass-Forming #Cholangiocarcinoma : The Role of R1vasc @Fla_doc @TorzilliGuido @simonefamularo

https://t.co/6qJjw6bCfb

@vitor__moutinho
@SyedAAhmad5

[GUIDO TORZILLI @TorzilliGuido]

Pleased to announce the online first publication on @AnnSurgOncol of the latest release about R1vasc Liver Surgery: pure R1vasc works also for MFCCC. @HumanitasMilano @HUNIMED @IHPBA @EAHPBA @AHPBA @APHPBA @Aicep4 @SSATNews @IASGO_1988

[GUIDO TORZILLI @TorzilliGuido]

It is my pleasure to share our latest release on Surgery disclosing a predictive model for communicating veins presence: key factor for liver tunnel, and upper trasversal hepatectomies. @IHPBA @EAHPBA @AHPBA @APHPBA @SSATNews @IASGO_1988 @HumanitasMilano @HUNIMED @Aicep4

[Flavio Milana @Fla_doc]

Excited to share our latest publication on leukocyte scores in iCCA patients undergoing liver resection!
🔗 Check it out here: https://t.co/Ekj1WjrXzS

@HumanitasMilano @UniAvogadro @TorzilliGuido @matteo_donadon @analleo @MichelaPolid @simonefamularo

[Simone Famularo @simonefamularo]

@SSATNews #FoundationReception the heroes of the closure @DDWMeeting @Fla_doc @ARuzzenente @YoKawaguchiUT @CDTzeng @TsengJennifer @a_burez

[AMMF @CharityAMMF]

Cholangiocarcinoma on chip! Dr. Michela Polidoro (@MichelaPolid) from @HumanitasMilano shared her fascinating research on developing a microfluid model that mimics the in-vivo-like CCA microenvironment #AMMF2024 #LiverTwitter

[GUIDO TORZILLI @TorzilliGuido]

24-28/6/2024: 1st ESSU Masterclass. 3D-cast planning, 3D-model printing, hands-on IOUS, live US-guided liver surgery. https://t.co/JG1ESZQvLi\https://t.co/vEJvqoWWv3 @HUNIMED @HumanitasMilano @IHPBA @EAHPBA @APHPBA2023 @AHPBA @SSATNews @IASGO_1988 @Aicep4 @SIC_chirurgia

[Valerie Chew @Valeriechew29]

Day 2 morning session of #EASL #LiverCancerSummit 2024 focusing on really important topics on AI and liq biomarkers for liver cancer. Great talks from @Caldera60373705 @maximeronot @ArndtVogel @Fla_doc!

[EASLnews @EASLnews]

@Fla_doc discusses combining blood inflammatory scores predicts survival and reflects the tumor niche in intrahepatic cholangiocarcinoma at #LiverCancerSummit 2024!

- The combination of blood inflammatory indexes resulted in the identification of two survival-risk profiles
- Adding CA19.9 identified a high-risk subgroup with an increased risk of recurrence
- A subgroup analysis on tumour microenvironment reflects the systemic results.

Future perspectives:
- A validation cohort is needed to confirm the results
- Tumour microenvironment dynamics need to be better investigated (e.g. characterising T cell phenotype: activation/exhaustion)
- These results and dynamics could help in the selection of patients who may benefit from dedicated follow-up and/or immunochemotherapy protocols.

[massimo iavarone @massimoiava]

@Fla_doc elegantly presented data on iCCA:
Combining blood inflammatory indexes resulted in the identification of two survival-risk profiles.
Adding Ca19.9 identified a high-risk subgroup with an increased risk of recurrence
@HumanitasMilano @analleo @TorzilliGuido @EASLedu

[Michela Polidoro @MichelaPolid]

Delighted to announce that I've been granted the Umberto Veronesi Foundation fellowship! 🧬🔬
Gratitude to @Fondaz_Veronesi for this exceptional opportunity!

[Ana Lleo @analleo]

🆘 CCA is a deadly cancer
🧬 preclinical research is key!

🆕 CCA-on-a-chip model just published in ⁦@JHEP_Reports⁩ ⁦@EASLnews⁩

🙏🏻support ⁦⁦@AIRC_it⁩
⁦@HUNIMED⁩ ⁦@polimi⁩ ⁦@RasponiMarco⁩ ⁦⁦@MichelaPolid⁩ https://t.co/cFs4vHtSoS

[Flavio Milana @Fla_doc]

@JHepatology Congrats @F__Colapietro !!!